Boston Scientific Corporation Share Price
Stocks
BSX
US1011371077
Advanced Medical Equipment & Technology
|
Market Closed -
NYSE
21:00:02 04/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 47.80 USD | +1.81% |
|
+2.05% | -49.87% |
| 09-04 | US companies face rise in cyber attacks | RE |
| 09-01 | Oncology firm Novocure says cyberattack exposed US patient records | RE |
| Market Cap | 69.27B 59.61B 56.08B 51.23B 95.84B 6,540B 96.1B 663B 257B 3,356B 260B 254B 10,811B | P/E 2026 * |
17.8x | P/E 2027 * | 18.8x |
|---|---|---|---|---|---|
| Enterprise Value | 77.99B 67.11B 63.14B 57.68B 108B 7,364B 108B 746B 290B 3,778B 293B 286B 12,171B | EV / Sales 2026 * |
3.65x | EV / Sales 2027 * | 3.35x |
| Free-Float |
82.47% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| BSX | Delayed | |
CBOE
| BSX | Real-time | |
|
Tradegate
| BSX | Real-time | |
|
Xetra
| BSX | Delayed | |
|
Boerse Muenchen
| BSX | Real-time | |
|
Börse Stuttgart
| BSX | Delayed | |
|
Wiener Boerse
| BSXC | End-of-day quote | |
|
Mexican S.E.
| BSX * | End-of-day quote | |
|
CBOE
| Real-time | ||
|
Borsa Italiana
| 1BSX | End-of-day quote | |
|
London S.E.
| 0HOY | Delayed | |
|
Deutsche Boerse AG
| BSX | Delayed | |
|
Swiss Exchange
| BSX | Delayed | |
|
Swiss Exchange
| BSX | Delayed | |
|
CBOE
| 0HOY | Real-time |
Last Transcript : Boston Scientific Corporation
| 1 day | +1.81% | ||
| 1 week | +2.05% | ||
| Current month | -1.04% | ||
| 1 month | +0.13% | ||
| 3 months | -1.54% | ||
| 6 months | -34.51% | ||
| Current year | -49.87% |
| 1 week | 46.09 |  | 49.66 |
| 1 month | 46.09 | | 52.99 |
| Current year | 42.2 | | 100.9 |
| 1 year | 42.2 | | 109.5 |
| 3 years | 42.2 | | 109.5 |
| 5 years | 34.98 | | 109.5 |
| 10 years | 19.67 | | 109.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 61 | 31/10/2011 |
Jonathan Monson
DFI | Director of Finance/CFO | 52 | 29/06/2025 |
Kenneth Stein
CTO | Chief Tech/Sci/R&D Officer | - | 31/08/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CHM | Chairman | 61 | 02/05/2016 |
Edward Ludwig
BRD | Director/Board Member | 74 | 28/02/2014 |
Ellen Zane
BRD | Director/Board Member | 74 | 14/04/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 25/08/26 | Buy | Director | 2,040 | 0.0001% | ||
| 11/08/26 | Other | Controller/Auditor | 2,930 | 0.0002% | ||
| 10/08/26 | Other | Chief Financial Officer | 9,908 | 0.0007% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.81% | +2.05% | -55.42% | -10.32% | 69.27B | |
| -0.75% | -1.35% | +24.60% | +13.24% | 227B | |
| -1.60% | -3.89% | +3.72% | -20.39% | 146B | |
| -0.85% | -1.58% | -21.45% | +19.18% | 130B | |
| +0.13% | -0.34% | +11.07% | +18.34% | 51.82B | |
| +0.49% | -1.32% | -17.44% | -13.87% | 50.45B | |
| +0.59% | -1.94% | +17.17% | +27.06% | 42.53B | |
| -1.01% | -1.28% | +33.64% | +48.14% | 40.22B | |
| -1.55% | +1.22% | +120.58% | +36.88% | 32.95B | |
| -0.37% | -4.98% | -17.58% | +48.39% | 32.94B | |
| Average | -0.31% | -1.90% | +9.89% | +16.66% | 82.27B | |
| Weighted average by Cap. | -0.53% | -1.69% | +5.69% | +9.66% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.37B 18.39B 17.3B 15.8B 29.56B 2,017B 29.64B 204B 79.32B 1,035B 80.23B 78.48B 3,334B | 22.33B 19.21B 18.08B 16.51B 30.89B 2,108B 30.97B 214B 82.89B 1,082B 83.84B 82.01B 3,484B |
| Net income | 3.84B 3.3B 3.11B 2.84B 5.31B 362B 5.33B 36.73B 14.25B 186B 14.42B 14.1B 599B | 3.69B 3.17B 2.98B 2.73B 5.1B 348B 5.11B 35.26B 13.68B 179B 13.84B 13.54B 575B |
| Net Debt | 8.72B 7.5B 7.06B 6.45B 12.06B 823B 12.09B 83.4B 32.36B 422B 32.73B 32.02B 1,360B | 5.45B 4.69B 4.41B 4.03B 7.54B 515B 7.56B 52.16B 20.24B 264B 20.47B 20.03B 851B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | US$47.80 | +1.81% | 15,504,234 |
| 03/09/26 | US$46.95 | -2.94% | 19,732,249 |
| 02/09/26 | US$48.37 | +0.60% | 17,017,972 |
| 01/09/26 | US$48.08 | -0.46% | 12,004,264 |
| 31/08/26 | US$48.30 | +3.12% | 18,906,225 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BSX Stock
Select your edition
All financial news and data tailored to specific country editions
